Baihakki, Benladdin H.

HRN: 11-59-17  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
CEFTRIAXONE 1G (VIAL)
03/18/2025
03/25/2025
IV
2g
Od
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: